Accelerated medical programs: A pathway to success or compromised education?
Bharti Jayshankar October 24, 2024: A recent study from New York University (NYU) Grossman School of Medicine has sparked renewed interest in the
Drugs
Health
Medical
Drugs
Health
Medical
Maternal eating disorder linked to increased psychiatric risks in offspring
Bharti Jayshankar October 24, 2024: In a Finnish population-based cohort study, researchers have found that mothers with a history of eating disorders or
Drugs
Health
Pharma
Merck acquires Yale University spinout Modifi Biosciences for up to $1.3 billion
Modifi Biosciences, Inc., a Yale University spinout company formed in 2021, has been acquired by Merck & Co. for about $1.3 billion to
Drugs
Health
Pharma
CDMO Samsung Biologics signs $1.24 billion drug manufacturing deal
Samsung Biologics has announced a $1.24 billion manufacturing deal with an unnamed Asian pharmaceutical company.
Climate
Health
Medical
Climate change intensifies wildfires and pollution-related deaths
HQ Team October 23, 2024: Rising global temperatures have led to more frequent and severe wildfires in vulnerable ecosystems like those found in
Drugs
Health
Medical
Alzheimer’s disease slowly enters the brain in a stealth mode
Alzheimer's disease has an initial silent and slow phase before the second stage of a destructive accumulation of plaques, tangles and other symptoms
Drugs
Health
Pharma
US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in
Health
Medical
Pharma
New portable handheld device delivers blood test results in an hour
HQ Team October 22, 2024: A new handheld device can isolate biomarkers for different diseases using sound waves from a single drop of
Drugs
Health
Medical
Hearing aids can delay onset, progression of Parkinson’s disease
HQ Team October 22, 2024: Hearing aids have emerged as a potentially significant factor in delaying the onset and progression of Parkinson’s disease
Drugs
Health
Pharma
Novo’s type 2 oral diabetic drug cuts heart diseases by 14% in a trial
Danish pharmaceutical company, Novo Nordisk’s oral semaglutide drug to treat type 2 diabetes helped reduce heart diseases by 14% compared to a dummy